Fariza Mezine manages the precision diagnostic platform, which develops innovative projects aimed at creating tools to better characterize allograft and xenograft rejection. The platform’s work relies on a multi-organ approach in both allo- and xenotransplantation, integrating molecular, histological, and clinical data to advance precision diagnostics in transplantation medicine.